Hepatitis B and C Infection in Gujrat, Pakistan: A Cross Sectional Study
DOI:
https://doi.org/10.51985/JBUMDC2019093Keywords:
Hepatitis B, Hepatitis C, PrevalenceAbstract
Objective: This study was aimed to investigate the prevalence of Hep B and C, gender distribution, route of transmission,
family history of Hepatitis and treatment options.
Study Design and Setting: This was a cross sectional study conducted at Dr Mujahid's Lab Bhimber road Gujrat, Pakistan.
Methodology: A total of 1181 individuals were included in this study. Among these 1181 individuals, 528 individuals were
screened for hepatitis B and C by immuno chromatographic test (ICT) at Dr. Mujahid’s Lab, Bhimber road, Gujrat while
rest of the 653 individuals were asked about the hepatitis status by using a well-structured questionnaire. Other related
questions were also included like age, sex, marital status, mode of transmission, and about treatment to evaluate the risk
factors associated with disease. Data was analyzed by using SPSS 17.
Results: Prevalence of hepatitis B and C was 1.37% and 8.26% in surveyed while 1.5% and 9.1% in screened population
of district Gujrat respectively. In surveyed hepatitis C patients, 72% were females and 28% were males. Among these, 91%
patients were married and only 9% were unmarried. In case of hepatitis C, 9% stated polluted water, 9% medicines, 5.5%
family history, 3.7% barber, 2% endemic, 2% dental surgery, 2% unhygienic food and 2% typhoid fever as a cause of
infection while for hepatitis B, 33% individual’s stated low standard hoteling as a cause of infection. Overall, incidence
of hepatitis was higher in screened individuals as compared to surveyed.
Conclusion: This study concluded that hepatitis prevalence is high in district Gujarat. Moreover, Hepatitis C is more
frequent than hepatitis B in this area.
References
World Health Organization fact sheets. Hepatitis C. Geneva:World Health Organization; 2000. Available at: http://www.who.int/mediacentre/factsheets/fs164/ en/(accessedAugust 2012).
World Health Organization: Western Pacific regional plan for hepatitis B control through immunization. Philippines: Regional Office for the Western Pacific Manila; [http://www.wpro. who.int/publications/publications.htm].
Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507–539.
Sood S, Malvankar S. Seroprevalence of Hepatitis B surface antigen, antibodies to the Hepatitis C virus, and human immunodeficiency virus in a hospital-based population in Jaipur, Rajasthan. Indian J Community Med. 2010;35:165–169. doi:
World Health Organization: Hepatitis C. Available at [http://www.who.int/mediacentre/ factsheets/fs164/en].
Qureshi H, Arif A, Riaz K, Alam SE, Ahmed W, Mujeeb SA. Determination of risk factors for hepatitis B and C in male patients suffering from chronic hepatitis. BMC Res Notes. 2009;2:212.
Bosan A, Qureshi H, Mohammad K, Ahmad I, Hafiz R. A review of hepatitis viral infections in Pakistan. J Pak Med Assoc. 2010;60(12):1045-1058.
Jafri W, Subhan A. Hepatitis C in Pakistan: magnitude, genotype, disease characteristics and therapeutic response. Trop Gastroenterol. 2008;29:194-120.
Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-Associated Hepatitis C. N. Engl. J. Med. 1995;332:1463-1466.
Petersen N, Barrett, Bond, Berquist, Favero, Bender, Maynard. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Applied and environmental microbiology. 1976;32:572-574.
Aslam M, Aslam J. Seroprevalence of the antibody to hepatitis C in select groups in Punjab region of Pakistan. J. Clin. Gast. 2001;33:407-11.
Najib UK, Lubna S, Ijaz A, Aqib I, Iqbal M, Farzana R, et al. Prevalence of hepatitis B in the blood donors of NW.F.P And FATA Regions and the current scenario of HBV infection in Pakistan. African Journal of Biotechnology. 2010;9(37):6162- 6166.
Abdul B, Kashif R, Iqbal A, Mehwish S, Sameerah M, Humera S, et al. Prevalence of Hepatitis B and C Infection in Pakistan. Journal of Infection and Molecular Biology 2014; 2(3):35– 38.
Mushtaq A, ariq MA, ashid U, froz A, eeshan N, sif AR, et al. Estimation of HCV viral load and liver enzymes among different patients groups of District Gujrat, Pakistan. ABB. 2013;4:866-871.
Rey–Cuille MA, Seck A, Njouom R, Chartier L, Sow HD, Njankouo M, et al. Low immune response to hepatitis B vaccine among children in Dakar, Senegal. PLoS One 2012;7(5):15–18.
Abdel HM, Kelly D. Chronic hepatitis B in children and adolescents: epidemiology and management. Pediatric Drugs 2013;15(4):311–317. doi: 10.1007/s40272-013-0010-z.
Adekeye AM, Chukwuedo AA, Zhakom PN, Yakubu RS. Prevalence of Hepatitis B and C among Blood Donors in Jos South LGA, Plateau State, Nigeria. Asian J. Med. Sci. 2013;5(5):101–104.
Ayele AG, Solomon GS. Prevalence and Risk Factors of Hepatitis B and Hepatitis C Virus Infections among Patients with Chronic Liver Diseases in Public Hospitals in Addis Ababa, Ethiopia. Trop. Med. 2013;2:1–7.
Wasfi OAS, Sadek NA. Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt. East. Medit. Health J.2011;3:238– 242.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Sajid Mehmood, Abdullah Mashori, Hira Khalid, Asim Mushtaq, Jagdesh, Muhammad Zeeshan Hyder
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
